Your browser doesn't support javascript.
loading
A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study.
An, Zhuo-Yu; Wu, Ye-Jun; Hou, Yu; Mei, Heng; Nong, Wei-Xia; Li, Wen-Qian; Zhou, Hu; Feng, Ru; Shen, Jian-Ping; Peng, Jun; Zhou, Hai; Liu, Yi; Song, Yong-Ping; Yang, Lin-Hua; Fang, Mei-Yun; Li, Jian-Yong; Cheng, Yun-Feng; Liu, Peng; Xu, Ya-Jing; Wang, Zhao; Luo, Yi; Cai, Zhen; Liu, Hui; Wang, Jing-Wen; Li, Juan; Zhang, Xi; Sun, Zi-Min; Zhu, Xiao-Yu; Wang, Xin; Fu, Rong; Huang, Liang; Wang, Shao-Yuan; Yang, Tong-Hua; Su, Li-Ping; Ma, Liang-Ming; Chen, Xie-Qun; Liu, Dai-Hong; Yao, Hong-Xia; Feng, Jia; Zhang, Hong-Yu; Jiang, Ming; Zhou, Ze-Ping; Wang, Wen-Sheng; Shen, Xu-Liang; Baima, Yangjin; Li, Yue-Ying; Wang, Qian-Fei; Huang, Qiu-Sha; Fu, Hai-Xia; Zhu, Xiao-Lu.
Afiliação
  • An ZY; Peking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China; Collaborative Innovation Center of Hematology, Peking University, Beijing 100044, China; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China; National Clinical
  • Wu YJ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China; Collaborative Innovation Center of Hematology, Peking University, Beijing 100044, China; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China; National Clinical
  • Hou Y; Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250014, China.
  • Mei H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430074, China.
  • Nong WX; Department of Hematology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi 832002, China.
  • Li WQ; Department of Hematology, Qinghai Provincial People's Hospital, Xining 810007, China.
  • Zhou H; Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Henan Institute of Hematology, Zhengzhou 450008, China.
  • Feng R; Department of Hematology, Beijing Hospital, Beijing 100044, China.
  • Shen JP; Department of Hematology, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou 310006, China.
  • Peng J; Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250014, China.
  • Zhou H; Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250014, China.
  • Liu Y; Department of Hematology, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100044, China.
  • Song YP; Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Henan Institute of Hematology, Zhengzhou 450008, China.
  • Yang LH; Department of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
  • Fang MY; Department of Hematology, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, China.
  • Li JY; Department of Hematology, The First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital), Nanjing 210029, China.
  • Cheng YF; Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Liu P; Department of Hematology, Xiangya Hospital, Central South University, Changsha 410008, China.
  • Xu YJ; Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing 100044, China.
  • Wang Z; Institute of Hematology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310058, China.
  • Luo Y; Department of Hematology, Beijing Tongren Hospital, Beijing 100005, China.
  • Cai Z; Department of Hematology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
  • Liu H; Department of Hematology, Beijing Hospital, Beijing 100044, China.
  • Wang JW; Department of Hematology, Beijing Tongren Hospital, Beijing 100005, China.
  • Li J; Department of Hematology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
  • Zhang X; Medical Center of Hematology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China.
  • Sun ZM; Department of Hematology, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China.
  • Zhu XY; Department of Hematology, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China.
  • Wang X; Department of Hematology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250014, China.
  • Fu R; Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, China.
  • Huang L; Institute of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430074, China.
  • Wang SY; Department of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
  • Yang TH; Department of Hematology, the First People's Hospital of Yunnan Province, Kunming 650032, China.
  • Su LP; Department of Hematology, Shanxi Tumor Hospital Affiliated to Shanxi Medical University, Taiyuan 030001, China.
  • Ma LM; Department of Hematology, Shanxi Bethune Hospital of Shanxi Medical University, Taiyuan 030001, China.
  • Chen XQ; Department of Hematology, The Affiliated Hospital of Northwest Hospital, Xi'an No.3 Hospital, Xi'an 710054, China.
  • Liu DH; Department of Hematology, Chinese PLA General Hospital & PLA Medical School, Beijing 100044, China.
  • Yao HX; Department of Hematology, Hainan Affiliated Hospital of Hainan Medical University, Hainan General Hospital, Haikou 570311, China.
  • Feng J; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen 518036, China.
  • Zhang HY; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen 518036, China.
  • Jiang M; Center of Hematologic Diseases, The First Affiliated Hospital of Xinjiang Medical University, Urumchi 830054, China.
  • Zhou ZP; Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650500, China.
  • Wang WS; Department of Hematology, Peking University First Hospital, Beijing 100034, China.
  • Shen XL; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi 046000, China.
  • Baima Y; Department of Hematology, People's Hospital of Tibet Autonomous Region, Lhasa 850000, China.
  • Li YY; Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and Development, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100029, China.
  • Wang QF; Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and Development, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100029, China.
  • Huang QS; Peking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China; Collaborative Innovation Center of Hematology, Peking University, Beijing 100044, China; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China; National Clinical
  • Fu HX; Peking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China; Collaborative Innovation Center of Hematology, Peking University, Beijing 100044, China; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China; National Clinical
  • Zhu XL; Peking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China; Collaborative Innovation Center of Hematology, Peking University, Beijing 100044, China; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China; National Clinical
Sci Bull (Beijing) ; 68(18): 2106-2114, 2023 09 30.
Article em En | MEDLINE | ID: mdl-37599175
ABSTRACT
Rare but critical bleeding events in primary immune thrombocytopenia (ITP) present life-threatening complications in patients with ITP, which severely affect their prognosis, quality of life, and treatment decisions. Although several studies have investigated the risk factors related to critical bleeding in ITP, large sample size data, consistent definitions, large-scale multicenter findings, and prediction models for critical bleeding events in patients with ITP are unavailable. For the first time, in this study, we applied the newly proposed critical ITP bleeding criteria by the International Society on Thrombosis and Hemostasis for large sample size data and developed the first machine learning (ML)-based online application for predict critical ITP bleeding. In this research, we developed and externally tested an ML-based model for determining the risk of critical bleeding events in patients with ITP using large multicenter data across China. Retrospective data from 8 medical centers across the country were obtained for model development and prospectively tested in 39 medical centers across the country over a year. This system exhibited good predictive capabilities for training, validation, and test datasets. This convenient web-based tool based on a novel algorithm can rapidly identify the bleeding risk profile of patients with ITP and facilitate clinical decision-making and reduce the occurrence of adversities.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Púrpura Trombocitopênica Idiopática Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Sci Bull (Beijing) Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Púrpura Trombocitopênica Idiopática Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Sci Bull (Beijing) Ano de publicação: 2023 Tipo de documento: Article